Transmyocardial laser revascularization for diffuse coronary artery disease: Early results
Transmyocardial revascularization (TMR) using a high energy CO2 laser has emerged as a new therapeutic option for patients with severe diffuse coronary artery disease refractory to conventional modes of therapy. TMR has shown symptomatic benefit and improvement in the exercise tolerance in a group o...
Saved in:
Published in | Current science (Bangalore) Vol. 77; no. 7; pp. 904 - 907 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Current Science Association
10.10.1999
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Transmyocardial revascularization (TMR) using a high energy CO2 laser has emerged as a new therapeutic option for patients with severe diffuse coronary artery disease refractory to conventional modes of therapy. TMR has shown symptomatic benefit and improvement in the exercise tolerance in a group of patients suffering from disabling angina, not amenable to other modes of treatment. However, this procedure resulted in 14 to 18% high early mortality in various series. The univariate predictors of mortality were age > 55 years, female sex, CKP > 1600 IU, absence of inter coronary collaterals, and mean PAP > 21 mm Hg. At one-year follow-up studies, a significant improvement in the angina class (II, III, IV), and treadmill testing (TMT) effort tolerance were observed; but without any significant change in the left ventricular ejection fraction. The high early mortality can be brought down with strict patient selection criteria. The mechanism of beneficial effects remains uncertain, and the patency of laser channels is controversial; but laser-induced neoangiogenesis is being looked upon as a plausible explanation. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0011-3891 |